O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.28B
AUM Growth
+$422M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
137
New
Increased
Reduced
Closed

Top Buys

1 +$120M
2 +$74.9M
3 +$73.6M
4
TRNX
TORNIER N V SHARES (NLD)
TRNX
+$60.8M
5
BMY icon
Bristol-Myers Squibb
BMY
+$59.3M

Top Sells

1 +$156M
2 +$123M
3 +$72.4M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$60M
5
XLRN
Acceleron Pharma
XLRN
+$57.6M

Sector Composition

1 Healthcare 84.96%
2 Financials 0.08%
3 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
51
$29.3M 0.34%
1,723,000
-170,000
52
$29.2M 0.34%
6,402,800
+105,800
53
$27M 0.32%
423,300
+100,300
54
$26.8M 0.31%
5,546,100
55
$24.9M 0.29%
400,000
-143,000
56
$23.4M 0.28%
1,172,000
-102,332
57
$21.8M 0.26%
+433,300
58
$19.1M 0.22%
+781,400
59
$19M 0.22%
277,000
+10,000
60
$18.2M 0.21%
+550,200
61
$17.6M 0.21%
4,238,000
62
$17.4M 0.2%
138,000
+5,000
63
$16.9M 0.2%
115,000
64
$16.7M 0.2%
1,075,400
65
$16.3M 0.19%
+180,600
66
$14.4M 0.17%
+218,100
67
$12.2M 0.14%
96,225
68
$11.6M 0.14%
111,100
69
$11.6M 0.14%
125,000
+45,000
70
$11.5M 0.14%
182,712
-74,586
71
$11.4M 0.13%
795,200
-1,317,800
72
$11.2M 0.13%
316,000
73
$11.2M 0.13%
121,850
74
$10.8M 0.13%
+538,500
75
$10.6M 0.12%
606
-26